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Title: THE UTILITY OF BIOMARKER EXCRETION RATES IN ACUTE KIDNEY INJURY (AKI)
Azrina Md Ralib1, John W Pickering1, Prasad Devarajan2 and Zoltan H Endre1. 1Medicine, University of Otago,
Christchurch, Canterbury, New Zealand and 2Cincinnati Children's Hospital Medical Center, Cincinatti, Ohio, United
States. 
INTRODUCTION AND AIMS: The urinary concentration of an AKI biomarker depends on the concentrating ability
of the kidney. To account for inter-individual variation, many studies index biomarkers to urine creatinine under the
assumption that urine creatinine concentration reflects water reabsorption. However, tubular secretion of creatinine
increases this concentration independently of water reabsorption. Measurement of excretion rates is an alternative
method of accounting for variability in water reabsorption. We compared urine concentration, excretion rate, and
indexed biomarker concentration (biomarker divided by creatinine concentration) in diagnosis of AKI and prediction
of death. We also assessed the relationship between total biomarker excretion and the severity of functional
change in AKI.
METHODS: Urinary concentrations of Alkaline Phosphatase (AP), -Glutamyl Transpeptidase (GGT), Cystatin C,
Neutrophil Gelatinase Associated Lipocalin (NGAL) and creatinine were measured on admission to the ICU, at 12h
and 24h in patients in the EARLYARF trial. The average urine flow rate was calculated from 4-hour creatinine
clearance measurements obtained at the same time points which allowed calculation of biomarker excretion rate.
The performance of absolute and indexed biomarker concentration, and of excretion rate in diagnosis of AKI (AKIN
definition: 0.3mg/dl or 50% increase in plasma creatinine from baseline) was assessed by receiver-operator
characteristic curve (ROC) analysis, with comparison of the area under curve (AUC) performed using the DeLong
method. Total excretion over 24h for each biomarker was calculated and the association with maximum AKIN
stages within 48 hours was analyzed using one-way ANOVA.
RESULTS: A total of 484 patients were analyzed; 44 patients were excluded from analysis because of collection
error and missing samples. For diagnosis, absolute biomarker concentration yielded the largest AUCs: AP: 0.54
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(0.48 to 0.59); GGT: 0.66 (0.60 to 0.71); Cystatin C: 0.68 (0.62 to 0.73); and NGAL: 0.71 (0.66 to 0.76). All AUC
values were marginally higher by 0.05 to 0.09 (p<0.0001) than for excretion rate or indexed biomarker
concentrations. For prediction of 7-day mortality, indexed biomarkers demonstrated the greatest AUCs: AP: 0.62
(0.54 to 0.71); GGT: 0.65 (0.56 to 0.73); Cystatin C: 0.67 (0.59 to 0.74); and NGAL: 0.66 (0.58 to 0.74). These
were larger by 0.04 to 0.09 compared to excretion rate and indexed biomarkers AUCs (indexed vs concentration:
all biomarkers p 0.05; indexed vs excretion rate: AP&GGT p 0.001, Cystatin C&NGAL p=0.06). Total excretion of
both Cystatin C and NGAL were correlated with maximum AKI severity (p<0.0001).
CONCLUSIONS: Indexing to creatinine or calculating a biomarker excretion rate did not improve the diagnostic
utility of urinary biomarker concentration for AKI. However, for prediction of mortality, indexing to urine creatinine
improved performance; this may result from capturing both cellular injury and loss of kidney concentrating
function. Both NGAL and Cystatin C total excretion reflected the severity of renal dysfunction in AKI.
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